Table 1. Clinical and serologic variables of the studied subjects.
Healthy Relatives | RA patients | P value | ||
---|---|---|---|---|
Anti-CCP2+ N = 12 |
Anti-CCP2- N = 12 |
N = 10 | ||
Age, yrs., mean ± SD | 35 ± 8.7 | 43 ± 14.8 | 41 ± 9.8 | 0.257 |
Female (%) | 75 | 91 | 80 | 0.534 |
Anti-CCP2 (U/ml), mean ± SD) | 35 ± 5.4* | 13 ± 1.7 | 194 ± 238.9* | 0.0001 |
FR (IU/ml, mean ± SD) | 6 ±3.5 | 7 ± 9.1 | 181 ± 178.2* | <0.0001 |
DAS28 | NA | NA | 5.8 ± 1.2 | - |
*Indicates significant differences for the anti-CCP2- group.